HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Nanotechnology and Drug Delivery Systems
Nanotechnology and Drug Delivery Systems
Nanotechnology has introduced transformative possibilities in cancer drug delivery systems. Nanocarriers, such as liposomes and polymer-based nanoparticles, enhance the precision and efficiency of delivering chemotherapeutic agents to tumor sites. These systems improve drug solubility, stability, and bioavailability while minimizing side effects by sparing healthy tissues. Advanced nanotechnology platforms also enable targeted delivery through ligand-receptor interactions, ensuring drugs reach specific cancer cells. Innovations in this field continue to refine treatment outcomes, offering a promising avenue for overcoming traditional chemotherapy limitations.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada Cancer Research 2026 Speakers
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Eleni Petsalaki
University of Crete, Greece
Can Küçük
Dokuz Eylul University, TurkeySubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Uncovering tumor-suppressive roles of histone modifiers in gastric cancer through spatial transcriptomics and epigenomics
Shilpa S Dhar, UT MD Anderson Cancer Center, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada
Title : A pioneering, first-of-its-kind Canadian off-site program designed to reduce the burden on hospital staff and optimize the use of space
Patricia Tai, University of Saskatchewan, Canada